Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
September 20th, 2020
4K views
Stem cell-based therapy has emerged as an efficient strategy to repair injured cardiac tissues after myocardial infarction. We provide an optimal in vivo application for stem cell transplantation using gelatin hydrogels that are able to be enzymatically cross-linked.
Overview
This study presents a novel approach for stem cell transplantation in cardiac tissue repair using enzymatically cross-linked gelatin hydrogels. The method aims to enhance the retention and survival of transplanted cells in infarcted hearts.
Key Study Components
Area of Science
- Cardiac tissue engineering
- Stem cell therapy
- Hydrogel applications
Background
- Current cardiac therapies face challenges such as low cell retention.
- Stem cell-based therapies are promising for myocardial infarction recovery.
- Injectable hydrogels can improve the delivery of therapeutic agents.
- In vivo models are essential for studying cardiac repair mechanisms.
Purpose of Study
- To develop a reliable technique for intramyocardial stem cell transplantation.
- To investigate the effectiveness of gelatin hydrogels in enhancing cell survival.
- To explore the potential of hydrogels for delivering growth factors and drugs.
Methods Used
- In vivo experiments using murine models.
- Enzymatically cross-linked gelatin hydrogels for stem cell delivery.
- Demonstration of procedures by research technologists.
- Assessment of cell retention and survival post-transplantation.
Main Results
- Improved retention of transplanted stem cells in cardiac tissues.
- Enhanced survival rates of cells using injectable hydrogels.
- Successful demonstration of the method in both in vitro and in vivo settings.
- Potential for hydrogels to deliver additional therapeutic agents.
Conclusions
- The method offers a feasible solution for cardiac tissue repair.
- Hydrogels can significantly improve the outcomes of stem cell therapies.
- This approach opens new avenues for cardiac regeneration research.
Frequently Asked Questions
What are gelatin hydrogels?
Gelatin hydrogels are biocompatible materials used for delivering cells and therapeutic agents in tissue engineering.
How does this method improve cell retention?
The method enhances cell retention by using hydrogels that provide a supportive environment for transplanted cells.
What is the significance of using murine models?
Murine models are crucial for studying the biological processes of cardiac repair and testing new therapies.
Can this technique be applied to other types of tissues?
While this study focuses on cardiac tissues, the technique may be adapted for other tissue engineering applications.
Who demonstrated the procedures in this study?
Eunmi Lee, Eun-Hye Park, and Eunhwa Seong, research technologists, demonstrated the procedures.
Executive Industry Relevance
Current cardiac stem cell therapies face challenges with low retention and survival of transplanted cells in infarcted myocardium, limiting therapeutic efficacy. This protocol introduces an injectable hydrogel platform to improve MSC delivery and engraftment in a murine myocardial infarction model. The approach supports preclinical evaluation of biomaterial-enhanced cell therapies for cardiac tissue repair and regeneration.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of stem cell engraftment mechanisms in ischemic tissue.
- Operational Value: Provides a reproducible model to assess cell survival post-transplantation.
Screening & Assay Development
- Scientific Value: Supports development of standardized hydrogel-based cell delivery systems.
- Operational Value: Facilitates quantitative assessment of MSC proliferation and survival in 3D culture.
Translational & Preclinical Research
- Scientific Value: Demonstrates functional improvement in cardiac structure and function post-MI.
- Operational Value: Enables longitudinal assessment via echocardiography and histology at day 28.
Pipeline & Workflow Integration
The method integrates into the discovery continuum by supporting early validation of stem cell delivery systems prior to lead optimization and preclinical efficacy studies.
- Discovery Biology: Tests hydrogel-mediated enhancement of MSC retention in infarcted myocardium.
- Screening: Enables standardized preparation and characterization of MSC-hydrogel constructs.
- Analytics: Provides quantitative readouts via live/dead staining, echocardiography, and histological analysis.
- Translational Research: Bridges in vitro findings to in vivo outcomes in a disease-relevant murine model.
- Enterprise Reuse: Establishes a platform adaptable for co-delivery of growth factors, genetic materials, or drugs.
Operational & Enterprise Impact
- Scientific Value: Improves predictive confidence in stem cell therapy outcomes by enhancing cell retention and survival.
- Operational Value: Offers a simple, in situ cross-linkable hydrogel system for reproducible cell delivery.
- Strategic Value: Reduces biological risk in cardiac regeneration programs by addressing a key limitation of cell therapies.
- Portfolio Impact: Supports risk-adjusted advancement of biomaterial-stem cell combinations for post-infarct heart failure prevention.
Implementation Considerations
- Requires expertise in mesenchymal stem cell culture and hydrogel preparation.
- Necessitates microsurgical skills for LAD ligation and intramyocardial injection in mice.
- Depends on standardized cell concentration and viability assessment via trypan blue exclusion.
- Requires controlled in vitro culture conditions to validate MSC proliferation prior to transplantation.
- Limited to small animal models; scalability to large animals or clinical settings requires further validation.
Biopharma FAQs
Why is intramyocardial injection used for MSC-hydrogel delivery post-MI?
Intramyocardial injection delivers MSC-loaded hydrogels directly to the infarct border zone to maximize local retention and engraftment in the injured myocardium.
How does in situ cross-linking of GH hydrogels support cell transplantation?
Enzymatic cross-linking occurs after injection, forming a stable hydrogel in situ that encapsulates MSCs and provides a supportive microenvironment for survival and proliferation.
What quantitative measurements enable assessment of MSC survival in hydrogels?
3D in vitro live-dead cell staining assay quantifies MSC survival and proliferation within GH hydrogels, showing branched networks and multicellular structures by day 14.
Why are echocardiography and histological analysis performed at day 28 post-transplantation?
These assessments evaluate long-term cardiac functional and structural outcomes, including fractional shortening, infarct size, fibrosis, and wall thickness, to determine therapeutic efficacy.
What statistical analysis is required to compare treatment groups in this murine MI model?
Comparative analysis of cardiac function and structural parameters across treatment groups requires statistical evaluation to determine significant improvements in the MSC gel-treated group versus controls.
Chapters in this video
0:05
Introduction
1:49
Preparation of MSCs and Injectable Gelatin Hydrogels
3:38
In Situ MSC-loading and Three-dimensional in Vitro Culture
4:29
Induction of Myocardial Infarction in Mice
5:44
Intramyocardial Transplantation of MSC-loading GH Hydrogels
6:37
Results: Improving Stem Cell Retention and Engraftment with Injectable Hydrogels
8:31
Conclusion
